Aegis Capital has reiterated a ‘Buy’ rating and price target of $14 on shares of Trevena, Inc. (NASDAQ: TRVN) following the company’s recent management meetings. Among other highlights from the meetings, the analyst noted Trevena’s completion of pre-launch commercial activity. Trevena has completed interviews with around 140 pharmacy directors and 40 anesthesiologists regarding Olinvo. As for the investors’ concerns regarding the launch of Olinvo in the U.S., the analyst believes it is worth launching and could be a product with peak year revenue in the range of $200 million-$300 million.
For more information, visit www.trevena.com
Trevena, Inc. is a biopharmaceutical company developing innovative therapies based on breakthrough science to benefit patients and healthcare providers confronting serious medical conditions. The company’s lead program is OLINVO™ (oliceridine injection), which has completed two successful phase 3 trials for the management of moderate-to-severe acute pain. Trevena has discovered four novel and differentiated drug candidates, including OLINVO. Trevena also has discovered TRV250, in early clinical development for the treatment of acute migraine. The Company maintains an early stage portfolio of drug discovery programs.
NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer